comparemela.com

Latest Breaking News On - Trista morrison - Page 18 : comparemela.com

Saniona AB: Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%

Saniona AB: Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3% December 17, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it was informed that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%. The financial impact of this potential acquisition to Saniona is not known at this time. Novartis and Cadent each announced today that Novartis intends to acquire all of the outstanding capital stock of Cadent. Upon the closing of the transaction, Cadent will receive a $210 million upfront payment and will be eligible for up to $560 million in milestone payments, for a total potential consideration of $770 million. Saniona holds an ownership stake of approximately 3% in Cadent resulting from Cadent s previous acquisition of the Saniona spin-out Ataxion, which was created to lev

Boston
Massachusetts
United-states
Denmark
Copenhagen
Køavn
Stockholm
Sweden
United-kingdom
Trista-morrison
Cadent-novartis-overview-press
Atlas-venture-inc

Investegate |Saniona AB Announcements | Saniona AB: Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%

Saniona AB Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3% Saniona was informed today that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3% PRESS RELEASE December 17, 2020 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it was informed that Novartis plans to acquire Cadent Therapeutics, in which Saniona holds an ownership stake of approximately 3%. The financial impact of this potential acquisition to Saniona is not known at this time. Novartis and Cadent each announced today that Novartis intends to acquire all of the outstanding capital stock of Cadent. Upon the closing of the transaction, Cadent will receive a $210 million upfront payment and will be eligible for up to $560 million in milestone payments, for a total potential consideration of $770 million. Saniona

Boston
Massachusetts
United-states
Denmark
Copenhagen
Køavn
Stockholm
Sweden
Trista-morrison
Atlas-venture-inc
Novartis
Cadent-therapeutics

Saniona's Ownership Stake in Scandion Oncology Reduced Below 5% Following Scandion's Successful Rights Issue – IT Business Net

Saniona's Ownership Stake in Scandion Oncology Reduced Below 5% Following Scandion's Successful Rights Issue – IT Business Net
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Trista-morrison
Scandion-oncology
Spotlight-stock-market
Chief-communications-officer
ட்ரிஸ்டா-மோரிசன்
ஸ்பாட்லைட்-ஸ்டாக்-சந்தை
தலைமை-தகவல்தொடர்புகள்-அதிகாரி
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.